Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast CancerShanu Modi, David Cameron, Aleix Prat et al.|New England Journal of Medicine|2022Cited by 2.5k
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancerAlessandra Gennari, Nadia Harbeck, Fabrice André et al.|Annals of Oncology|2021Cited by 1.4k
Enhancing global access to cancer medicinesJavier Cortés, Joaquı́n Arribas, José Manuel Pérez-García et al.|CA A Cancer Journal for Clinicians|2020Cited by 205
Performance of PD-L1 immunohistochemistry (IHC) assays in unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC): Post-hoc analysis of IMpassion130H. S. Rugo, Leisha A. Emens, Sherene Loi et al.|Annals of Oncology|2019Cited by 115